GALAPAGOS NV-SPON ADR (GLPG)

Galapagos Enters Oversold Territory (GLPG)

RSI Alert: Galapagos (GLPG) Now Oversold

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline

Galapagos Breaks Above 200-Day Moving Average - Bullish for GLPG

GLPG Makes Notable Cross Below Critical Moving Average

Galapagos enters into strategic collaboration with Thermo Fisher (NASDAQ:GLPG)

Galapagos NV enters strategic collaboration with Thermo Fisher for decentralized manufacturing of CAR-T product in San Francisco area, effective January...

Galapagos signs development deal with BridGene (NASDAQ:GLPG)

Galapagos (GLPG) has entered into a strategic collaboration deal with BridGene Biosciences, with Galapagos receiving the exclusive right to commercialize any resulting products.

BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

/PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditional "hard-to-drug" targets, announced today a...

Galapagos to transfer Jyseleca business to Alfasigma (NASDAQ:GLPG)

Galapagos (GLPG) Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. Per the terms, Galapagos will receive a €50 million payment upfront..

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023

GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galapagos (NASDAQ:GLPG) just reported results for the third quarter of 2023.Gal...

Oversold Conditions For Galapagos (GLPG)

Galapagos Enters Oversold Territory (GLPG)

Galapagos Breaks Above 200-Day Moving Average - Bullish for GLPG

Galapagos GAAP EPS of €0.40, revenue of €178.9M (NASDAQ:GLPG)

Galapagos press release (GLPG): Q1 GAAP EPS of €0.40.Revenue of €178.9M (+31.3% Y/Y).Current financial investments and cash and cash equivalents totaled €3,990.1 million on 31 March...

Galapagos announces departure of COO and CFO Bart Filius (NASDAQ:GLPG)

Galapagos (GLPG) notifies the departure of Bart Filius, President, Chief Operating Officer and Chief Financial Officer.Bart Filius will leave the company as per 30 June 2023.A search...

Relative Strength Alert For Galapagos

Galapagos stock dips as Jyseleca fails phase 3 trial as induction therapy in Crohn's

Galapagos (GLPG) stock fell ~8% on Thursday after filgotinib failed to meet the main goals as induction therapy in a phase 3 trial in patients with moderate to severe Crohn's...

Galapagos announces changes to executive committee (NASDAQ:GLPG)

Galapagos (GLPG) announced Dr. Walid Abi-Saab has decided to retire from the company as Chief Medical Officer and member of the executive committee, effective 31 December 2022.He will...

SDGR stock, VTYX stock rise after Takeda deal for psoriasis candidate (NASDAQ:SDGR)

Schrödinger (SDGR) and Ventyx Biosciences (VTYX) rallied Tuesday after Takeda (TAK) agreed to pay $4B upfront to acquire a company developing a TYK2 inhibitor. Read full story here.

Galapagos Enters Oversold Territory (GLPG)